Carole L. Wallis

4.2k citations

82 papers · 2.2k indexed · h-index 26

Co-authors: Wendy Stevens Tobias F. Rinke de Wit Kim Sigaloff Raph L Hamers Margaret Siwale John W. Mellors Cissy Kityo Kishor Mandaliya
Topics: HIV/AIDS drug development and treatment (58 papers)HIV/AIDS Research and Interventions (56 papers)HIV Research and Treatment (55 papers)
Cited by: Virology Infectious Diseases Epidemiology
Journals: SHILAP Revista de lepidopterologíaPLoS ONE Clinical Infectious Diseases
Partner nations: South Africa United States Netherlands

In The Last Decade

Carole L. Wallis

81 papers receiving 2.2k citations

Peers

Countries citing papers authored by Carole L. Wallis

Since Specialization

Citations

This map shows the geographic impact of Carole L. Wallis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole L. Wallis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole L. Wallis more than expected).

Fields of papers citing papers by Carole L. Wallis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole L. Wallis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole L. Wallis. The network helps show where Carole L. Wallis may publish in the future.

Co-authorship network of co-authors of Carole L. Wallis

This figure shows the co-authorship network connecting the top 25 collaborators of Carole L. Wallis. A scholar is included among the top collaborators of Carole L. Wallis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole L. Wallis. Carole L. Wallis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations 2023 ·Southern African Journal of HIV Medicine ·(unknown),François Venter,(unknown),Nectarios Papavarnavas,Pauline Howell,Gillian Sorour,Carole L. Wallis,Katherine Gill,Francesca Conradie,Linda‐Gail Bekker	3
2	Undiagnosed Pulmonary Tuberculosis (TB) and Coronavirus Disease 2019 (COVID-19) in Adults Dying at Home in a High-TB-Burden Setting, Before and During Pandemic COVID-19: An Autopsy Study 2023 ·Clinical Infectious Diseases ·(unknown),Tanvier Omar,Minja Milovanovic,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Carole L. Wallis,(unknown),Limakatso Lebina,Ebrahim Variava,Neil Martinson	2
3	Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis 2021 ·AIDS Patient Care and STDs ·(unknown),Jason Roy,Michael Z. Levy,Carole L. Wallis,(unknown),Catherine Godfrey,Ann C. Collier,(unknown),(unknown),Xin Sun,Robert Gross	2
4	Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020 2020 ·Southern African Journal of HIV Medicine ·Linda‐Gail Bekker,(unknown),Dvora Joseph Davey,Katherine Gill,Michelle Moorhouse,Sinéad Delany‐Moretlwe,Landon Myer,Catherine Orrell,Kevin Rebe,François Venter,Carole L. Wallis	28
5	Two-way mobile phone intervention compared with standard-of-care adherence support after second-line antiretroviral therapy failure: a multinational, randomised controlled trial 2019 ·The Lancet Digital Health ·Robert Gross,Justin Ritz,Michael D. Hughes,Robert A. Salata,Peter Mugyenyi,Evelyn Hogg,(unknown),Catherine Godfrey,Carole L. Wallis,John W. Mellors,Victor Mudhune,Sharlaa Badal‐Faesen,Beatriz Grinsztejn,Ann C. Collier	23
6	Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection 2015 ·The Journal of Infectious Diseases ·Anne Derache,Carole L. Wallis,Saran Vardhanabhuti,John Bartlett,Nagalingeswaran Kumarasamy,David Katzenstein	9
7	HIV Type 1 Transmission Networks Among Men Having Sex with Men and Heterosexuals in Kenya 2013 ·AIDS Research and Human Retroviruses ·Daniela Bezemer,Nuno R. Faria,Amin S. Hassan,Raph L Hamers,Gaudensia Mutua,Omu Anzala,Kishor Mandaliya,Patricia Cane,James A. Berkley,Tobias F. Rinke de Wit,Carole L. Wallis,Susan M. Graham,Matt A. Price,Roel A. Coutinho,Eduard J. Sanders	32
8	Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial 2013 ·PLoS ONE ·Prudence Ive,William MacLeod,(unknown),Catherine Orrell,Ute Jentsch,Carole L. Wallis,Wendy Stevens,Robin Wood,Ian Sanne,Debika Bhattacharya	14
9	Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol 2013 ·Journal of Virological Methods ·(unknown),Susan C. Aitken,Carole L. Wallis,Kim Steegen,Lieven Stuyver,Tobias F. Rinke de Wit,Wendy Stevens	5
10	HIGH RESOLUTION COMPUTED TOMOGRAPHY (HRCT) IN ONE YEAR OLD CF NEWBORN SCREENED (NBS) INFANTS: NOT A USEFUL OUTCOME MEASURE 2012 ·UCL Discovery (University College London) ·(unknown),Alistair Calder,(unknown),(unknown),(unknown),Carole L. Wallis,Alan S. Brody	2
11	Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies 2012 ·Clinical Infectious Diseases ·Raph L Hamers,Kim Sigaloff,Annemarie M. J. Wensing,Carole L. Wallis,Cissy Kityo,Margaret Siwale,Kishor Mandaliya,Prudence Ive,(unknown),Melanie Wellington,Akin Osibogun,Wendy Stevens,Tobias F. Rinke de Wit,Rob Schuurman,(unknown)	137
12	Genotype assays and third-line ART in resource-limited settings 2012 ·AIDS ·(unknown),Michael D. Hughes,Beatriz Grinsztejn,Ann C. Collier,Paula M. Luz,Kenneth A. Freedberg,Robin Wood,Julie H. Levison,Peter Mugyenyi,Robert A. Salata,Carole L. Wallis,Milton C. Weinstein,Robert T. Schooley,Rochelle P. Walensky	23
13	Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings 2012 ·AIDS ·John Bartlett,Heather J. Ribaudo,Carole L. Wallis,Evgenia Aga,David Katzenstein,Wendy Stevens,Michael Norton,Karin L. Klingman,Mina C. Hosseinipour,John A. Crump,Khuanchai Supparatpinyo,Sharlaa Badal‐Faesen,Beatrice Kallungal,Nagalingeswaran Kumarasamy	32
14	Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa 2012 ·The Journal of Infectious Diseases ·Kim Sigaloff,Raph L Hamers,Carole L. Wallis,Cissy Kityo,Margaret Siwale,Prudence Ive,(unknown),Kishor Mandaliya,Melanie Wellington,Akin Osibogun,Wendy Stevens,Michèle van Vugt,Tobias F. Rinke de Wit,(unknown)	55
15	Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa 2011 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Kim Sigaloff,Raph L Hamers,Carole L. Wallis,Cissy Kityo,Margaret Siwale,Prudence Ive,Mariëtte E. Botes,Kishor Mandaliya,Maureen Wellington,Akin Osibogun,Wendy Stevens,Michèle van Vugt,Tobias F. Rinke de Wit	151
16	HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study 2011 ·The Lancet Infectious Diseases ·Raph L Hamers,Carole L. Wallis,Cissy Kityo,Margaret Siwale,Kishor Mandaliya,Francesca Conradie,Mariëtte E. Botes,Maureen Wellington,Akin Osibogun,Kim Sigaloff,Immaculate Nankya,Rob Schuurman,Ferdinand W N M Wit,Wendy Stevens,Michèle van Vugt,Tobias F. Rinke de Wit	228
17	HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Raph L Hamers,Margaret Siwale,Carole L. Wallis,(unknown),(unknown),Wendy Stevens,Rob Schuurman,Annemarie M. J. Wensing,Michèle van Vugt,Tobias F. Rinke de Wit	31
18	Natural Polymorphisms of integrase Among HIV Type 1-Infected South African Patients 2010 ·AIDS Research and Human Retroviruses ·(unknown),Raymond Hewer,Carole L. Wallis,François Venter,Wendy Stevens,Maria A. Papathanasopoulos	29
19	Characterization of HIV Type 1 Genetic Diversity Among South African Participants Enrolled in the AIDS Vaccine Integrated Project (AVIP) Study 2010 ·AIDS Research and Human Retroviruses ·Maria A. Papathanasopoulos,Eftyhia Vardas,Carole L. Wallis,Richard H. Glashoff,Stefano Buttò,Guido Poli,Mauro Malnati,Mario Clerici,Barbara Ensoli	10
20	Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1 2009 ·Journal of Virological Methods ·Carole L. Wallis,Maria A. Papathanasopoulos,Shabir Lakhi,Etienne Karita,Anatoli Kamali,Pontiano Kaleebu,Eduard J. Sanders,Omu Anzala,Linda‐Gail Bekker,Gwynn Stevens,Tobias F. Rinke de Wit,Wendy Stevens	51

About Carole L. Wallis

Carole L. Wallis is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 82 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (58 papers), HIV/AIDS Research and Interventions (56 papers) and HIV Research and Treatment (55 papers). The work is most often cited by research in Virology (1.5k citations), Infectious Diseases (1.9k citations) and Epidemiology (466 citations). Carole L. Wallis has collaborated with scholars based in South Africa, United States and Netherlands. Frequent co-authors include Wendy Stevens, Tobias F. Rinke de Wit, Kim Sigaloff, Raph L Hamers, Margaret Siwale, John W. Mellors, Cissy Kityo, Kishor Mandaliya, Akin Osibogun and François Venter. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact